Responding to global healthcare needs
Serves as the U.S. government’s centralized distributor of COVID-19 vaccines and ancillary supply kits; McKesson Europe distributes COVID-19 vaccines in several countries.
Pharmacies owned/operated by McKesson in the U.S., Canada and Europe remained open during the COVID-19 pandemic providing medication access, testing and vaccinations in select stores.
Investing in solutions to improve patient outcomes
Transforms patient access, adherence and cost of specialty medications with the launch of Access for More Patients™.
Expands Biologics by McKesson’s specialty pharmacy capabilities for rare and complex conditions.
2017 – 2018
Forging new strategic ventures to expand healthcare expertise
Forms healthcare IT joint venture with Change Healthcare to deliver wide-ranging financial, operational and clinical benefits.
Acquires CoverMyMeds® to provide patients cost-effective solutions for medications.
Announces Medical Specialties Distributors acquisition to create new solutions that improve alternate-site delivery and distribution of patient care delivery.
2007 – 2016
Transforming the fight against cancer
Expands oncology expertise with the acquisitions of Biologics and Vantage Oncology.
Becomes a leader in specialty cancer care with the acquisitions The US Oncology Network and US Oncology Research.
Establishes expertise in oncology with the acquisition of Oncology Therapeutics Network and Onmark Group Purchasing Organization.
1991 – 2006
Accelerating global leadership in healthcare
Continues investing in the Health Mart franchise, now the nation’s largest network of independent pharmacies.
Acquires RelayHealth, the nation’s leading pharmacy network.
Gains traction in Canada with the acquisition of Medis Health and Pharmaceutical Services.
1833 – 1960
Building a best-in-class supply chain
John McKesson and Charles Olcott, two young entrepreneurs, open Olcott & McKesson, a drug import and wholesale business in 1833.
Becomes the largest U.S. distributor of wholesale pharmaceutical drugs, beverages and chemicals.
Exits investment in Change Healthcare and moves forward executing against strategic growth initiatives as a more focused organization.
Advances cancer care and research with the launch of Ontada™, an oncology technology and insights business.
Acquires online prescription fulfillment business, Echo, to accelerate the transition to digital and improve medication access for U.K. patients.
Acquires RxCrossroads to provide biopharma manufacturers customizable services and solutions.
Expands footprint by acquiring HBO & Company, the world’s largest healthcare services company.
Acquires General Medical Supply, the nation's largest distributor of medical supplies and equipment.
Forms the first-ever nationwide wholesale pharmaceutical drug distribution network.
Forms a joint venture between McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (SCRI) to transform oncology research, accelerate drug development and increase availability and access to clinical trials in the community setting.
Strategically realigns McKesson’s Prescription Technology Solutions, including CoverMyMeds, Prescription Automation, RelayHealth and RxCrossroads, under the new CoverMyMeds® brand.
Expanding community services to bring healthcare closer to home
2021 – Present
Acquires Rx Savings Solutions to help make prescription medications more affordable for patients.